 Moving on the response of the perspective on technology, we'll have two aspects now, one linked to the medical technology and the other one to the information technology that supports the environment. We will start with Sungwoo on the medical technologies, please. Okay, thank you for giving me a great opportunity to discuss our DSP issues. So I'd like to focus on three issues. One is that prevention versus treatment. And second issue is the massive screening versus a point of care test. Thirdly, I'd like to mention about the innovative point of care test to ubiquitous health care. The one is that in USA, the National Institute of Health NIH, they focused, they invested huge money over 50 years on the cancer drug development. But after they said they couldn't find any progress, the ratio of the patient was almost the same. After the investment, they made some conclusions. They changed their policy to prevention rather than treatment. Then so many pharmaceutical companies changed their future or investment direction. Now the prevention means to include the vaccine development or the diagnostic. This field is very important. If you prevent the disease before the treatment, it will be much effective. Actually, it seems that it is more effective. And last year, we have a COVID pandemic. In the beginning of last year, WHO announced that a pandemic started. But each country tried to get the right detection systems. So in Korea, too, many diagnostic companies generated so much the PCR diagnostic kit and also the machines and provided for the massive screening. But the massive screening has one critical problem. Transportation of the human samples after you get the samples from the hospital. You have to transport. Usually it takes a long time. So that is also a cost. And also during the transportation, your samples in the beginning, the sample transportation, for the transportation, they made a very special packaging. Three layers of the special packaging are not to spread out the virus. So that was, of course, made a much cost and also made a mistake. Also a mix of the samples. That kind of thing made some wrong result for some people. But for the massive screening purpose, it was fine. But if they had a point of care test system on that point, also still now, then they can do, they can handle the sample on site. Our first samples can be analyzed and then we can provide the data very quickly. Without any cost or duration time for the transportation. It will be a great method, but still, we are not ready. So nobody made a so compact, great, inexpensive system. But maybe the government, also every company wanted to generate that kind of invention. So that is the one critical point. And then, then why, so if, how can you handle the supervising disease at this time after the corona or with the corona? So possibly if we can, this kind of point of care test system at home or in a private hospital, then you can use this one more efficiently and then more effectively. So for this, we need some special technology that is, we need innovation, innovative technology. So how can you make them? So I think the government should make some policy to generate this kind of need technology. So we need a huge investment for this. So many companies are trying to make this one. But in the beginning, mostly new technology comes from the venture, the startup companies. They concentrate on the new technology. They want to make it commercialized by the health of the big companies. So there, the startup companies cannot get funded well. So who's going to sponsor them? The government may need this kind of sponsoring system. So if they can get enough money, enough investment and concentration, they can make a very fast, accurate, compact, inexpensive portable systems can be generated. If that is generated, we can use this one at home or at any place in the field. Then those, they can collect the data on site. They can send this data visual to the hospital or to the control tower. Especially in the control tower, in the servers, whole data can be collected. Using this big data system, we can be assisted by artificial intelligence. Using this kind of combination, we can control the, we can expect. Estimate the next, the disease or what kind of disease will appear in different seasons, different locations. So this one will be there are good approaches. So many companies want to approach this way. But still, we need a critical part, innovation. So I like to focus and emphasize this innovative technology. In this way, we can apply to the ubiquitous healthcare on the future. So everybody can use a hand-held size or wearable size of detection system at home. And then they can track their health and then they can provide this data to hospital. Then they can collect in the government control tower, the center for this control. They can provide a good policy to control the disease and for the better life. That will be the, I think, future world. So if I provide one simple hour of the cases, we are working with WHO and also we are working with Institute of Parts Center in Senegal. Especially in Senegal, they adopted our system. We are co-developing together. They have the huge number of the clinical samples from the African countries. And we have some innovative technology. We provide it. We could make a very efficient way of the point-of-care system. And then we hope we can make a better system together. And also, we are communicating with a double nature. They are also providing good information and guidance. In that way, we can find a real need from the real world. So we hope we can make this kind of cooperation for the good solution. Thank you so much. Thank you, Sungwoo, for the practical proposition. On the previous panel, we heard that one of the lessons from the COVID crisis was the need to better anticipate and the need for the preparation. And if I understand well here, you're proposing a priority that says the preparation should lead to ubiquitous or instantaneous healthcare. And this requires also the type of infrastructure that you describe and that definitely cannot be built overnight. So thank you for this input.